Presented at Diabetes Workshop 2017 in conjunction with World Diabetes Day. Organized by Malaysian Endocrine & Metabolic Society and Hospital Putrajaya. 15th November 2017.
Presented at Diabetes Workshop 2017 in conjunction with World Diabetes Day. Organized by Malaysian Endocrine & Metabolic Society and Hospital Putrajaya. 15th November 2017.
Evaluation and Management of Behaviors in Persons with Cognitive ImpairmentVITAS Healthcare
The goal of this webinar is to enable healthcare clinicians to implement a comprehensive approach to non-pharmacologic and pharmacologic management of dementia-related behaviors for the benefit of patients and their caregivers.
The recognition of bipolar disorder in primary careNick Stafford
Bipolar disorder and the complexities of screening and diagnosis in primary care. How more accurate detection and an integrated care pathway with secondary care can improve the diagnosis and outcome of the treatment of the disorder.
Team Based Care for Hypertension Management a biopsychosocial approachMichael Changaris
This presentation is an overview of the collaborative care model of hypertension management for behavioral health providers, primary care doctors and health care teams. It explored social determinants of health, complex interaction of adverse childhood experiences and treatment and provides a map for integrated care.
Integrated Behavioral Health: Approaches to hypertension, toxic stress, ment...Michael Changaris
•TEAM BASED CARE: Team-based care incorporates a multidisciplinary team, centered on the patient, to optimize the quality of hypertension care. •TEAM PLAYERS: Team-based care includes the patient, the primary care clinician, and other professionals such as nurses, pharmacists, physician assistants, dieticians, social workers, and community health workers, each with pre-defined responsibilities in care. •OUTCOMES: Review and Meta-analysis of 100 randomized trials determined that team-based care is highly effective compared with other strategies for BP control.
Evaluation and Management of Behaviors in Persons with Cognitive ImpairmentVITAS Healthcare
The goal of this webinar is to enable healthcare clinicians to implement a comprehensive approach to non-pharmacologic and pharmacologic management of dementia-related behaviors for the benefit of patients and their caregivers.
The recognition of bipolar disorder in primary careNick Stafford
Bipolar disorder and the complexities of screening and diagnosis in primary care. How more accurate detection and an integrated care pathway with secondary care can improve the diagnosis and outcome of the treatment of the disorder.
Team Based Care for Hypertension Management a biopsychosocial approachMichael Changaris
This presentation is an overview of the collaborative care model of hypertension management for behavioral health providers, primary care doctors and health care teams. It explored social determinants of health, complex interaction of adverse childhood experiences and treatment and provides a map for integrated care.
Integrated Behavioral Health: Approaches to hypertension, toxic stress, ment...Michael Changaris
•TEAM BASED CARE: Team-based care incorporates a multidisciplinary team, centered on the patient, to optimize the quality of hypertension care. •TEAM PLAYERS: Team-based care includes the patient, the primary care clinician, and other professionals such as nurses, pharmacists, physician assistants, dieticians, social workers, and community health workers, each with pre-defined responsibilities in care. •OUTCOMES: Review and Meta-analysis of 100 randomized trials determined that team-based care is highly effective compared with other strategies for BP control.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Diabetes and Psychiatric Disorders - Can they co-exist_Evelyn Parrish.PPTX
1. Diabetes and Psychiatric
Disorders: Can they Co-exist?
Evelyn Parrish, PhD, APRN-BC
Associate Professor
College of Nursing
University of Kentucky
2. Objectives
Upon completion of this activity, participants will be able to:
• Discuss the impact of mental health comorbidities on
diabetes management.
4. Prevalence
Physical and Psychiatric
Physical and psychiatric illnesses are closely interwoven.
60% of patients needing mental health care are being
treated by medical practitioners
50-80% of the patients treated in medical clinics have a
diagnosable psychiatric illness, and 10-20% of medical
patients suffer primarily from an emotional disorder
50% of patients in psychiatric clinic populations have
undiagnosed medical conditions
10% of self-referred psychiatric patients have symptoms
that are due solely to a medical illness
5. Prevalence of Diabetes
• Diabetes is a serious global health issue, currently affecting 425 million people
world wide
• By 2045 it is expected to affect 690 million people world wide
https://www.idf.org/aboutdiabetes/live-your-life-in-style.html
8. Treatment Challenges
• Psychiatric disorders in patients with diabetes has a low detection rate
• Approximately 50% of those with a psychiatric disorder is not recognized nor
treated in patients diabetes
9. Psychological Issues
• Diabetic regimen and dietary considerations
• Blood sugar monitoring
• Insulin injection
• Fear of hyperglycemia
• Fear of hypoglycemia
• Fear of injection
• Decrease in quality of life
10. Common Co-Morbid Diabetes and Psychiatric
Disorder
• Diabetes Mellitus type I: Major Depression and Obsessive Compulsive
Disorder
• Diabetes Mellitus type II: Major Depression and Somatization Disorder
12. Prevalence of Depression
• Mental and Behavioral Disorders are leading cause of disability
globally
• Leading cause of disability in the U.S. age 18-25
• Affects approximately 16 millionAmerican adults
• Prevalent in women than in men
https://www.nami.org/NAMI/media/NAMI-Media/Infographics/GeneralMHFacts.pdf
https://www.nimh.nih.gov/health/statistics/index.shtml
13. Prevalence of
Diabetes and Depression
• Doubles risk of having depression, approximately 1 in
every 5 patients are affected
• The rate of Depression for the general population is 3-5%
the rate with Diabetes is between 15-20%
• Depression is under-recognized and undertreated in
patients with Diabetes
• When they co-exist, they may worsen the other
15. Symptoms of Depression in
Patients with Diabetes
• Impaired quality of life
• Increased cost of care
• Poor treatment adherence
• Poor glycemic control
• Increased ED visits due diabetic ketoacidosis
• Disruptions in life (family, social, work)
18. Anxiety Disorders
• Patients with diabetes are 20% more likely to have an anxiety disorder
• Patients with diabetes have increased rates of obsessive compulsive disorder,
post-traumatic stress disorder, and agoraphobia
• Difficulty differentiating symptoms of diabetes from anxiety disorders
19. Symptoms of Anxiety in Patients with Diabetes
• Fear
• Sweating
• Tremor
• Tachycardia
• Confusion
21. Treatment
• Assess severity- PHQ9, BDI, State-Trait Anxiety Scale,
etc.
• Education regarding illness, severity, and treatment
• Antidepressants, anxiolytics, etc.
• Psychotherapy
22. Ramifications of Failure to Achieve
Remission
• Higher rate of relapse
• Higher utilization of medical services
• Lowered quality of life
• Workplace issues
23. Treatment Resistant Depression
• 60-70% have favorable response
• 5-10% fail to respond
-Failure to respond leads to questions of
appropriate diagnosis and treatment
-Undiagnosed medical illness is a major factor in failure to
respond
25. Summary
• Diagnosis of a chronic medical condition serves as sufficient
suspicion for an in-depth screening for psychiatric co-
morbidities
• Diagnosis of a psychiatric disorder serves as sufficient
suspicion for an in-depth screening for associated physical
conditions
• Goal is for symptom remission, improved quality of life, and
improved management of chronic physical illness and level of
functioning
26. Take Away Message
• Co-mordity of diabetes and psychiatric disorders is common and can have
different presentations
• Psychological approaches can improve therapeutic adherence in diabetes care
• Patient engagement and empowerment are essential components of their
care
